Pharmacokinetics of a metoprolol prolonged-release tablet in Chinese healthy volunteers

李雪宁,陈伟力,徐红蓉,诸骏仁,李志善
DOI: https://doi.org/10.3969/j.issn.1007-4406.2004.05.001
2004-01-01
Abstract:AIM: To evaluate the safety and pharmacokinetic parameters of a metoprolol prolonged-release tablet in healthy Chinese volunteers. METHODS: Twenty-two healthy Chinese volunteers were given a single and multiple oral dose 50 mg of metoprolol prolonged-release tablet. The concentration of metoprolol in blood plasma was measured by an validated HPLC fluorescence method and was assessed with non-compartment model to obtain the pharmacokinetic parameters. RESULTS: The pharmacokinetic parameters of metoprolol prolonged-release formulation for orally administered (122.55 +53.93)% after multiple doses. CONCLUSION: The results show that tmax(5.8 vs 5 h) is similar in Chinese volunteers with that as reports in caucasuians,but cmax(23.3vs 48.62 μg·L-1), Cmin(6.73 vs 26.71 μg·L-1) and DF are different after multiple doses. Tmax(5.8 vs 1.1 h),cmax(15.67 x 2 vs 186.2 μg·L-1) of metoprolol prolongedrelease tablet are significantly different with those of the conventional tablet of metoprolol after single dose in Chinese volunteers.No any adverse drug reactions such as hypotension,dizziness,etc occur during the whole study.
What problem does this paper attempt to address?